Company / Depreciation & Amortization
Corbus Pharmaceuticals Holdings, Inc. Depreciation & Amortization History
FY2015-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$999.8K
FY2022
5-year range
$255.7K / $1.1M
FY2018-FY2022
Trend
-11.0%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Increased from $739,378 to $999,817 over the past 2 years.
Based on SEC 10-K filings.
$999,817 in FY2022 with a 5-year CAGR of +86.8%.
Increased from $739,378 to $999,817 over the past 2 years.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- +26.5%
- 5-Year CAGR
- +86.8%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +86.8%, indicating consistent growth.
- In FY2022, depreciation & amortization decreased 11.0% year-over-year.
- Peak depreciation & amortization was recorded in FY2021.
- Lowest depreciation & amortization in the period was in FY2015.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -12.48 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | $999.8K | -11.0% |
| FY2021 | $1.1M | +52.0% |
| FY2020 | $739.4K | +49.7% |
| FY2019 | $493.9K | +93.2% |
| FY2018 | $255.7K | +481.8% |
| FY2017 | $43.9K | +0.0% |
| FY2016 | $43.9K | +322.3% |
| FY2015 | $10.4K | - |
As of FY2022 · SEC 10-K · Updated Jun 24, 2026